Furthermore, curcumin reduces EGFR protein expression in Erlotinib-resistant NSCLC (H1650) cells, hence enhancing the efficiency of Erlotinib, the recommended drug to combat lung cancer [299, 316]. Here, EGFR is linked to lung carcinoma.